HeyJaredPharmaSource Podcast
Welcome to the PharmaSource podcast: the pharma and biotech podcast that explores the latest trends, challenges, and commercial opportunities shaping the biopharma manufacturing and outsourcing.In each episode we'll be speaking with top executives, researchers, and…
- Indexed episodes, last 90 days
- 25
- Latest publication
- Sep 28, 2026
- Audience
- Checking…
- Earliest in this view
- Jul 6, 2026
Latest episodes
What Changes When Pharma Outsources Outcomes, Not Just People? (opens the original)
Read excerpt
“Traditional staff augmentation says, ‘Here are the people you asked for.’ An outcome-led model says, ‘Here is the service or capability you asked for, and we are accountable and responsible for making it work.’” — Aisling Flanagan Aisling Flanagan, Global SVP of Professional and Managed Services at Catalyx, leads people-based services for regulated manufacturing environments. She works alongside Mike Barrett, Catalyx’s director of sales and operations for the UK and Europe, who focuses on trans
Europe Needs to Pick a Side: Why Geopolitics Is Forcing a Rethink of Pharma Supply Network Design (opens the original)
Read excerpt
Sponsored by Blue Jet Healthcare, this panel at CDMO Live Europe 2026 brought together Bernhard Boehm , Head of External Manufacturing Animal Health, Boehringer Ingelheim; Philip Coetzee , Director CMO Management, Daiichi Sankyo Europe; Fanny Eberhardt , Director Global Procurement, UCB; and Shiven Arora , Managing Director, Blue Jet Healthcare to debate how pharma companies are making network strategy decisions as cost pressures, geopolitical risk, and the limits of tech transfer collide. Read
AI in Biopharma Manufacturing: Why Build-or-Buy Is the Wrong First Question (opens the original)
Read excerpt
“AI is marketed as such an approachable, ubiquitous thing that everybody thinks they can vibe code it. Unfortunately, a lot of companies are starting to think that way,” says Kat Kozyrytska. Kat Kozyrytska is a portfolio strategy and technology leader in life science technologies who has operated across organizations, including Sartorius and Thermo Fisher, and now advises across the life sciences ecosystem. Her work focuses on translating emerging technologies, including AI, automation, and digi
What CDMOs Get Wrong About AI for Bioprocessing, According to Sapiens Health’s Seungik Cho (opens the original)
Read excerpt
“How good is your AI model? That’s the wrong question. The right question is: what does your AI model actually help your company do?” Seungik Cho , founder of Sapiens Health, has spent the past year pulling apart the assumption in biomanufacturing that a better-predicting AI model means a better digital twin. His research argues the opposite: that optimizing AI for prediction accuracy can cause these systems to fail in CDMO environments. Seungik Cho is the founder of Sapiens Health and Director
How to Identify a Root Cause Without Delay: Interlabor's Troubleshooting Framework (opens the original)
Read excerpt
At CDMO Live Europe 2026, Dr. Olivier Aebischer , Deputy CEO at Interlabor Belp AG, demonstrated how a structured, dual-path analytical approach can identify manufacturing root causes in days, using two real contamination case studies from the lab’s operations.
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Not enough subject data for this period yet.
Audience
No verified audience measurement yet.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.